Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
Appendix C: Panel Roster and Financial Disclosures
Last Updated: April 1, 2016; Last Reviewed: April 1, 2016
|Bowen, Anna||Centers for Disease Control and Prevention||Procter and Gamble||Research Support|
|Pham, Paul||University of Maryland & Westview Urgent Care Medi Center||None||N/A|
|Sears, Cynthia*||Johns Hopkins University||Clinical Infectious Diseases||Other|
|Merieux Institute||Research Support|
|Wanke, Christine||Tufts University Medical School||GlaxoSmithKline||Research Support|
|Pfizer||Clinical Trial Even Adjucation|
|* Group lead
Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from April 1, 2014, through April 1, 2016.
- CDC | 2015 STD Treatment Guidelines
- HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
- AIDSinfo Patient Materials: What is an Opportunistic Infection?
- AIDSource | HIV-Related Conditions
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Adult and Adolescent OI Guidelines Archive